Literature DB >> 990159

Cardiovascular effects of labetalol during halothane anaesthesia.

D B Scott, F P Buckley, G B Drummond, D G Littlewoods, W R Macrae.   

Abstract

1 The circulatory effects of labetalol 25 mg intravenously in six patients during 1% halothane anaesthesia were studied. 2Labetalol caused a marked decrease in arterial pressure and a consistent but modest (20%) decrease in cardiac output. Heart rate was slowed and stroke volume did not change significantly. Central venous pressure increased and peripheral resistance decreased. 3 Increasing the halothane concentration of 3% led to marked myocardial depression as evidenced by reduced cardiac output and increased central venous pressure with increasing arterial hypotension. 4 Labetalol may be a suitable drug for controlling induced hypotension under general anaesthesia, although high concentrations of halothane should be used with care.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990159

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

Review 1.  Induced hypotension during anesthesia with special reference to orthognathic surgery.

Authors:  C Rodrigo
Journal:  Anesth Prog       Date:  1995

Review 2.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

3.  The influence of labetalol on arterial blood gas data, pulmonary haemodynamics and pulmonary shunting.

Authors:  S G De Hert; L G Heytens; R G De Jongh; M P Vercauteren; E A Boeckx; H F Adriaensen
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

4.  Use of labetalol during halothane anaesthesia.

Authors:  D H Cope
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  The use of labetalol in anaesthesia.

Authors:  D B Scott
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 6.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

Review 7.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

8.  Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.

Authors:  L Kaufman
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

9.  Evaluation of the efficacy of desflurane with or without labetalol for hypotensive anesthesia in middle ear microsurgery.

Authors:  Neha Gupta; Vandana Talwar; Smita Prakash; Achyut Deuri; Anoop Raj Gogia
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.